Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.
about
microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicityA link between mir-100 and FRAP1/mTOR in clear cell ovarian cancerAn integrative paradigm to impart quality to correlative science.MicroRNA: important player in the pathobiology of multiple myelomaHigh-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2.Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity.A Comprehensive Review of Dysregulated miRNAs Involved in Cervical Cancer.Circulating miRNA markers show promise as new prognosticators for multiple myeloma.Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis.Down-regulated miR-22 as predictive biomarkers for prognosis of epithelial ovarian cancer.MicroRNAs: New Players in Multiple Myeloma.MicroRNAs in urine are not biomarkers of multiple myelomaIntegrating the multiple dimensions of genomic and epigenomic landscapes of cancer.Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomideMicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid MalignanciesThe Role of miRNA in Haematological Malignancy.MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma.Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases.Deregulated microRNAs in multiple myeloma.DNA methylation of microRNA genes in multiple myeloma.Non-coding RNA: a novel opportunity for the personalized treatment of multiple myeloma.MTA1-activated Epi-microRNA-22 regulates E-cadherin and prostate cancer invasiveness.Mir-221/222 are promising targets for innovative anticancer therapy.Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphomaEpigenetics in Multiple Myeloma.Expression signatures of intragenic miRNAs and their corresponding host genes in myeloid leukemia cells.The non-coding oncogene: a case of missing DNA evidence?Insights into the regulation of human CNV-miRNAs from the view of their target genesDownregulation of miRNA-15a and miRNA-16 promote tumor proliferation in multiple myeloma by increasing CABIN1 expression.Old and Young Actors Playing Novel Roles in the Drama of Multiple Myeloma Bone Marrow Microenvironment Dependent Drug Resistance.MicroRNA-542-3p suppresses tumor cell proliferation via targeting Smad2 inhuman osteosarcoma.
P2860
Q54749810-27F930EC-D8CB-4286-BE54-B6C0EEF2C6FDQ54813731-14E36708-4CA4-42C4-A104-87877794F029Q54835150-01025A0C-9C1F-4100-8913-189C3987FC62Q54898954-6DABDB36-2F2A-4F9A-9536-105C61DE19D8Q54900043-379E74CE-AEDD-46DA-A794-5901F5A6E9F9Q54900162-43406AAF-F1E7-4A1C-A393-BB2CC2993BE4Q54900168-E944596F-5650-4DDE-8A73-2758BAC5ADAFQ54900170-EFB97CC8-6443-451E-82AF-16260AB3DB5FQ54900171-B4F96BF4-9450-45DA-8133-0D66E88BF064Q54900175-888838D0-40E1-4C90-B01F-09494F804633Q54900176-1470FAC9-D310-452B-B0A1-24DEC10BACD5Q54900177-28316056-FFC5-47F0-8B10-95F1265B00B6Q54900182-51DE006D-344D-4AC7-910E-62641290680AQ54908142-9D349749-DBFB-48FA-AFE4-DFC100C7FD17Q54936482-D174421C-417F-4C30-B41C-72C55AD0F0A7Q54951245-E43E4D06-CF46-4941-A010-ADD9F28F5CBC
P1343
Q24620203-259694B5-3D08-4884-AE04-6CA95BB5847DQ33634277-F9538A8F-00A5-4EC6-9023-15866A1C4780Q33765942-02AE2BB5-D6DC-44F7-B984-9C92FEA52DEEQ33786861-D6E7700E-FB8E-4D26-8E01-CBF50E9A1809Q33842759-1DFA4024-ACE1-42C7-B2A0-2407E87ABCA0Q33917555-BB62802B-3897-41E7-94EF-AA646F27E6A7Q34049716-E73DD46A-F0FE-45DB-9996-A9853FB4C5EFQ34135498-CF294710-5BE4-42FF-9156-E12F5ADF0293Q34254020-84FA491E-76DD-4160-A0C4-FE8126FC0D96Q34268397-81D4FA0F-DD8B-4775-A7A2-048EAD3B772AQ35711092-D0D7B269-C7D8-445A-900D-A1D05C3E393AQ36089046-0CF6B2AC-FEDA-49D0-88B8-EE19B402C089Q36152246-4581E838-8D00-4997-95EC-1669FBDAC127Q36172671-E4FFEACB-A0F6-4EC7-AF9D-6844CD0DA6A0Q36525161-F5ED2593-42BE-4DDF-BC6D-33BD119EB9DCQ36544516-F3DD26C3-9C5B-4096-840E-3DF514AC3C78Q36602853-67895CD9-F247-4BC7-9E40-8A88128611C6Q37422388-6B58DB70-E392-4FBB-A515-60D8B60CD823Q37636762-E9706FD6-5571-467C-8BC1-DE8967AA9D44Q37643929-E7B6C304-CC70-490E-866F-B3901E4EA8A7Q37916411-1D901A28-24F4-4BD4-BD37-B2E1F6B4DBC0Q38020153-A11351C6-DEDF-41D6-B834-9A49BC86F116Q38108387-FFB4D769-63FB-4F1A-BD7A-965B0CA9291BQ38715226-126DA254-1857-4589-850F-68431839222CQ38767024-03EB58D5-60FB-445E-8E40-9E0A5419539EQ38846167-48542AE3-6FFD-4AED-B8BC-24A1FD0F2A52Q38970577-B5B03D32-5982-4C49-BEF4-4DD7F1F428F4Q39308686-2F9DAF23-746F-4EE8-9FAD-0B0E6D0C801EQ39551053-F58C6DB7-17B9-423D-A309-9DC1B9B1BE48Q41822575-6F985BBC-DD17-41F8-B0CB-62B49E6DA110Q49272569-B18BBEA4-CEA5-4CFC-BB4B-77FC9339B790Q55025408-39611BAA-D1D7-465D-8F73-E693713B74FEQ55335524-7433CE7E-AB8F-47FC-BF49-D58F29358775
P2860
Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Integrative high-resolution mi ...... and gene expression profiles.
@en
Integrative high-resolution mi ...... and gene expression profiles.
@nl
type
label
Integrative high-resolution mi ...... and gene expression profiles.
@en
Integrative high-resolution mi ...... and gene expression profiles.
@nl
prefLabel
Integrative high-resolution mi ...... and gene expression profiles.
@en
Integrative high-resolution mi ...... and gene expression profiles.
@nl
P2093
P2860
P4510
P50
P356
P1476
Integrative high-resolution mi ...... s and gene expression profiles
@en
P2093
Adrian Andronache
Giorgio Lambertenghi Deliliers
Marta Lionetti
P2860
P304
P356
10.1002/GCC.20660
P577
2009-06-01T00:00:00Z